T1	B-Protein	B-Protein	0	4	Oct2	Oct2	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	5	20	transactivation	transactivation	I-NP	NN	O	8	SUB	O
O	O	O	21	25	from	from	B-PP	IN	O	2	NMOD	O
O	O	O	26	27	a	a	B-NP	DT	O	7	NMOD	O
T11	B-Entity	B-Entity	28	34	remote	remote	I-NP	JJ	B-DNA	7	NMOD	B-DNA
T11	I-Entity	I-Entity	35	43	enhancer	enhancer	I-NP	NN	I-DNA	7	NMOD	I-DNA
T11	I-Entity	I-Entity	44	52	position	position	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	53	61	requires	require	B-VP	VBZ	O	0	ROOT	O
O	O	O	62	63	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	64	65	B	B	I-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	O	65	66	-	-	B-NP	HYPH	I-cell_type	12	P	I-cell_type
O	O	O	66	70	cell	cell	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	70	71	-	-	B-NP	HYPH	O	12	P	O
O	O	O	71	81	restricted	restrict	I-NP	VBN	O	15	NMOD	O
O	O	O	82	90	activity	activity	I-NP	NN	O	8	OBJ	O
O	O	O	90	91	.	.	O	.	O	8	P	O

O	O	O	93	101	Previous	Previous	B-NP	JJ	O	3	NMOD	O
O	O	O	102	116	cotransfection	cotransfection	I-NP	NN	O	3	NMOD	O
O	O	O	117	128	experiments	experiment	I-NP	NNS	O	4	SUB	O
O	O	O	129	132	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	133	145	demonstrated	demonstrate	I-VP	VBN	O	4	VC	O
O	O	O	146	150	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	O	151	158	ectopic	ectopic	B-NP	JJ	O	8	NMOD	O
O	O	O	159	169	expression	expression	I-NP	NN	O	17	SUB	O
O	O	O	170	172	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	173	176	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	177	187	lymphocyte	lymphocyte	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	187	188	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
O	O	O	188	196	specific	specific	I-NP	JJ	I-protein	16	NMOD	I-protein
O	O	O	197	210	transcription	transcription	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	211	217	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T2	B-Protein	B-Protein	218	222	Oct2	Oct2	I-NP	NN	B-protein	9	PMOD	B-protein
O	O	O	223	228	could	could	B-VP	MD	O	6	SBAR	O
O	O	O	229	240	efficiently	efficiently	I-VP	RB	O	17	VMOD	O
O	O	O	241	249	activate	activate	I-VP	VB	O	17	VC	O
O	O	O	250	251	a	a	B-NP	DT	O	21	NMOD	O
T12,T13	B-Entity,B-Entity	B-Entity,B-Entity	252	260	promoter	promoter	I-NP	NN	B-DNA	19	OBJ	B-DNA
T12	I-Entity	I-Entity	261	271	containing	contain	B-VP	VBG	O	21	NMOD	O
T12	I-Entity	I-Entity	272	274	an	an	B-NP	DT	O	25	NMOD	O
T12,T14	I-Entity,B-Entity	I-Entity,B-Entity	275	282	octamer	octamer	I-NP	NN	B-DNA	25	NMOD	B-DNA
T12,T14	I-Entity,I-Entity	I-Entity,I-Entity	283	288	motif	motif	I-NP	NN	I-DNA	22	OBJ	I-DNA
O	O	O	288	289	.	.	O	.	O	4	P	O

T3	B-Protein	B-Protein	290	294	Oct2	Oct2	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	295	305	expression	expression	I-NP	NN	O	3	SUB	O
O	O	O	306	309	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	310	316	unable	unable	B-ADJP	JJ	O	3	PRD	O
O	O	O	317	319	to	to	B-VP	TO	O	6	VMOD	O
O	O	O	320	329	stimulate	stimulate	I-VP	VB	O	4	AMOD	O
O	O	O	330	331	a	a	B-NP	DT	O	11	NMOD	O
T15	B-Entity	B-Entity	332	344	multimerized	multimerized	I-NP	JJ	B-DNA	11	NMOD	B-DNA
T15	I-Entity	I-Entity	345	352	octamer	octamer	I-NP	NN	I-DNA	11	NMOD	I-DNA
T15	I-Entity	I-Entity	353	361	enhancer	enhancer	I-NP	NN	I-DNA	11	NMOD	I-DNA
T15	I-Entity	I-Entity	362	369	element	element	I-NP	NN	I-DNA	6	OBJ	I-DNA
O	O	O	370	372	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	373	377	HeLa	HeLa	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	378	383	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	O	383	384	,	,	O	,	O	3	P	O
O	O	O	385	392	however	however	B-ADVP	RB	O	3	VMOD	O
O	O	O	392	393	.	.	O	.	O	3	P	O

O	O	O	394	396	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	397	401	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	402	408	tested	test	I-VP	VBN	O	2	VC	O
O	O	O	409	410	a	a	B-NP	DT	O	5	NMOD	O
O	O	O	411	418	variety	variety	I-NP	NN	O	3	OBJ	O
O	O	O	419	421	of	of	B-PP	IN	O	5	NMOD	O
T4	B-Protein	B-Protein	422	426	Oct2	Oct2	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	427	435	isoforms	isoform	I-NP	NNS	I-protein	6	PMOD	I-protein
O	O	O	436	445	generated	generate	B-VP	VBN	O	8	NMOD	O
O	O	O	446	448	by	by	B-PP	IN	O	9	VMOD	O
O	O	O	449	460	alternative	alternative	B-NP	JJ	O	12	NMOD	O
O	O	O	461	469	splicing	splicing	I-NP	NN	O	10	PMOD	O
O	O	O	470	473	for	for	B-PP	IN	O	12	NMOD	O
O	O	O	474	477	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	478	488	capability	capability	I-NP	NN	O	29	NMOD	O
O	O	O	489	491	to	to	B-VP	TO	O	17	VMOD	O
O	O	O	492	500	activate	activate	I-VP	VB	O	15	NMOD	O
O	O	O	501	503	an	an	B-NP	DT	O	20	NMOD	O
T16	B-Entity	B-Entity	504	511	octamer	octamer	I-NP	NN	B-DNA	20	NMOD	B-DNA
T16	I-Entity	I-Entity	512	520	enhancer	enhancer	I-NP	NN	I-DNA	17	OBJ	I-DNA
O	O	O	521	523	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	524	535	nonlymphoid	nonlymphoid	B-NP	JJ	B-cell_type	23	NMOD	B-cell_type
O	O	O	536	541	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	O	542	545	and	and	O	CC	O	29	NMOD	O
O	O	O	546	547	a	a	B-NP	DT	O	29	NMOD	O
O	O	O	548	549	B	B	I-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	O	549	550	-	-	B-NP	HYPH	I-cell_line	29	NMOD	I-cell_line
O	O	O	550	554	cell	cell	I-NP	NN	I-cell_line	29	NMOD	I-cell_line
O	O	O	555	559	line	line	I-NP	NN	I-cell_line	13	PMOD	I-cell_line
O	O	O	559	560	.	.	O	.	O	2	P	O

O	O	O	561	564	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	565	573	analyses	analysis	I-NP	NNS	O	3	SUB	O
O	O	O	574	578	show	show	B-VP	VBP	O	0	ROOT	O
O	O	O	579	583	that	that	B-SBAR	IN	O	15	DEP	O
O	O	O	584	591	several	several	B-NP	JJ	O	7	NMOD	O
T5	B-Protein	B-Protein	592	596	Oct2	Oct2	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	597	605	isoforms	isoform	I-NP	NNS	I-protein	8	SUB	I-protein
O	O	O	606	609	can	can	B-VP	MD	O	4	SBAR	O
O	O	O	610	619	stimulate	stimulate	I-VP	VB	O	8	VC	O
O	O	O	620	624	from	from	B-PP	IN	O	9	VMOD	O
O	O	O	625	626	a	a	B-NP	DT	O	13	NMOD	O
O	O	O	627	633	remote	remote	I-NP	JJ	O	13	NMOD	O
O	O	O	634	642	position	position	I-NP	NN	O	10	PMOD	O
O	O	O	643	646	but	but	O	CC	O	15	DEP	O
O	O	O	647	651	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	652	656	this	this	B-NP	DT	O	17	NMOD	O
O	O	O	657	668	stimulation	stimulation	I-NP	NN	O	18	SUB	O
O	O	O	669	671	is	be	B-VP	VBZ	O	15	SBAR	O
O	O	O	672	682	restricted	restricted	B-ADJP	JJ	O	18	PRD	O
O	O	O	683	685	to	to	B-PP	TO	O	19	AMOD	O
O	O	O	686	687	B	B	B-NP	NN	B-cell_type	22	NMOD	B-cell_type
O	O	O	688	693	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	O	693	694	.	.	O	.	O	3	P	O

O	O	O	695	699	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	700	706	result	result	I-NP	NN	O	3	SUB	O
O	O	O	707	716	indicates	indicate	B-VP	VBZ	O	0	ROOT	O
O	O	O	717	720	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	721	732	involvement	involvement	I-NP	NN	O	3	OBJ	O
O	O	O	733	735	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	736	742	either	either	O	CC	O	18	NMOD	O
O	O	O	743	744	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	745	746	B	B	I-NP	NN	B-cell_type	11	NMOD	B-cell_type
O	O	O	746	747	-	-	B-NP	HYPH	I-cell_type	11	P	I-cell_type
O	O	O	747	751	cell	cell	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	O	751	752	-	-	B-NP	HYPH	O	18	P	O
O	O	O	752	760	specific	specific	I-NP	JJ	O	14	NMOD	O
O	O	O	761	769	cofactor	cofactor	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	770	772	or	or	O	CC	O	18	NMOD	O
O	O	O	773	774	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	775	783	specific	specific	I-NP	JJ	O	18	NMOD	O
O	O	O	784	796	modification	modification	I-NP	NN	O	6	PMOD	O
O	O	O	797	799	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	800	801	a	a	B-NP	DT	O	21	NMOD	O
O	O	O	802	810	cofactor	cofactor	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	811	813	or	or	O	CC	O	25	NMOD	O
O	O	O	814	817	the	the	B-NP	DT	O	25	NMOD	O
T6	B-Protein	B-Protein	818	822	Oct2	Oct2	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	823	830	protein	protein	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	O	831	833	in	in	B-PP	IN	O	5	NMOD	O
T7	B-Protein	B-Protein	834	838	Oct2	Oct2	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	O	838	839	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	O	839	847	mediated	mediate	I-NP	VBN	O	31	NMOD	O
T17	B-Entity	B-Entity	848	856	enhancer	enhancer	I-NP	NN	O	31	NMOD	O
O	O	O	857	867	activation	activation	I-NP	NN	O	26	PMOD	O
O	O	O	867	868	.	.	O	.	O	3	P	O

O	O	O	869	879	Mutational	Mutational	B-NP	JJ	O	2	NMOD	O
O	O	O	880	888	analyses	analysis	I-NP	NNS	O	3	SUB	O
O	O	O	889	897	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	898	902	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	903	906	the	the	B-NP	DT	O	9	NMOD	O
T18	B-Entity	B-Entity	907	914	carboxy	carboxy	I-NP	NN	B-protein	9	NMOD	B-protein
T18	I-Entity	I-Entity	914	915	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T18	I-Entity	I-Entity	915	923	terminal	terminal	I-NP	JJ	I-protein	9	NMOD	I-protein
T18	I-Entity	I-Entity	924	930	domain	domain	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	931	933	of	of	B-PP	IN	O	9	NMOD	O
T8	B-Protein	B-Protein	934	938	Oct2	Oct2	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	O	939	941	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	O	942	950	critical	critical	B-ADJP	JJ	O	12	PRD	O
O	O	O	951	954	for	for	B-PP	IN	O	13	AMOD	O
T19	B-Entity	B-Entity	955	963	enhancer	enhancer	B-NP	NN	O	16	NMOD	O
O	O	O	964	974	activation	activation	I-NP	NN	O	14	PMOD	O
O	O	O	974	975	.	.	O	.	O	3	P	O

O	O	O	976	984	Moreover	Moreover	B-ADVP	RB	O	5	VMOD	O
O	O	O	984	985	,	,	O	,	O	5	P	O
O	O	O	986	990	this	this	B-NP	DT	O	4	NMOD	O
O	O	O	991	997	domain	domain	I-NP	NN	O	5	SUB	O
O	O	O	998	1007	conferred	confer	B-VP	VBD	O	0	ROOT	O
O	O	O	1008	1017	enhancing	enhancing	B-NP	NN	O	7	NMOD	O
O	O	O	1018	1026	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	O	1027	1031	when	when	B-ADVP	WRB	O	5	VMOD	O
O	O	O	1032	1037	fused	fuse	B-VP	VBN	O	8	SBAR	O
O	O	O	1038	1040	to	to	B-PP	TO	O	9	VMOD	O
O	O	O	1041	1044	the	the	B-NP	DT	O	13	NMOD	O
T9	B-Protein	B-Protein	1045	1049	Oct1	Oct1	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1050	1057	protein	protein	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	O	1057	1058	,	,	O	,	O	13	P	O
O	O	O	1059	1064	which	which	B-NP	WDT	O	13	NMOD	O
O	O	O	1065	1067	by	by	B-PP	IN	O	18	VMOD	O
O	O	O	1068	1074	itself	itself	B-NP	PRP	O	16	PMOD	O
O	O	O	1075	1078	was	be	B-VP	VBD	O	15	SBAR	O
O	O	O	1079	1085	unable	unable	B-ADJP	JJ	O	18	PRD	O
O	O	O	1086	1088	to	to	B-VP	TO	O	21	VMOD	O
O	O	O	1089	1098	stimulate	stimulate	I-VP	VB	O	19	AMOD	O
O	O	O	1099	1103	from	from	B-PP	IN	O	21	VMOD	O
O	O	O	1104	1105	a	a	B-NP	DT	O	25	NMOD	O
O	O	O	1106	1112	remote	remote	I-NP	JJ	O	25	NMOD	O
O	O	O	1113	1121	position	position	I-NP	NN	O	22	PMOD	O
O	O	O	1121	1122	.	.	O	.	O	5	P	O

O	O	O	1123	1126	The	The	B-NP	DT	O	6	NMOD	O
T20	B-Entity	B-Entity	1127	1136	glutamine	glutamine	I-NP	NN	B-protein	6	NMOD	B-protein
T20	I-Entity	I-Entity	1136	1137	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T20	I-Entity	I-Entity	1137	1141	rich	rich	I-NP	JJ	I-protein	6	NMOD	I-protein
T20	I-Entity	I-Entity	1142	1152	activation	activation	I-NP	NN	I-protein	6	NMOD	I-protein
T20	I-Entity	I-Entity	1153	1159	domain	domain	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	1160	1167	present	present	B-ADJP	JJ	O	6	NMOD	O
O	O	O	1168	1170	in	in	B-PP	IN	O	7	AMOD	O
O	O	O	1171	1174	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1175	1180	amino	amino	I-NP	JJ	B-protein	13	NMOD	B-protein
O	O	O	1180	1181	-	-	I-NP	HYPH	I-protein	13	NMOD	I-protein
O	O	O	1181	1189	terminal	terminal	I-NP	JJ	I-protein	13	NMOD	I-protein
O	O	O	1190	1197	portion	portion	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	1198	1200	of	of	B-PP	IN	O	13	NMOD	O
T10	B-Protein	B-Protein	1201	1205	Oct2	Oct2	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	O	1206	1209	and	and	O	CC	O	19	NMOD	O
O	O	O	1210	1213	the	the	B-NP	DT	O	19	NMOD	O
T21	B-Entity	B-Entity	1214	1217	POU	POU	I-NP	NN	B-protein	19	NMOD	B-protein
T21	I-Entity	I-Entity	1218	1224	domain	domain	I-NP	NN	I-protein	20	SUB	I-protein
O	O	O	1225	1235	contribute	contribute	B-VP	VBP	O	0	ROOT	O
O	O	O	1236	1240	only	only	B-ADVP	RB	O	20	VMOD	O
O	O	O	1241	1251	marginally	marginally	B-ADVP	RB	O	21	AMOD	O
O	O	O	1252	1254	to	to	B-PP	TO	O	20	VMOD	O
O	O	O	1255	1258	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	1259	1274	transactivation	transactivation	I-NP	NN	O	26	NMOD	O
O	O	O	1275	1283	function	function	I-NP	NN	O	23	PMOD	O
O	O	O	1284	1288	from	from	B-PP	IN	O	26	NMOD	O
O	O	O	1289	1290	a	a	B-NP	DT	O	30	NMOD	O
O	O	O	1291	1297	distal	distal	I-NP	JJ	O	30	NMOD	O
O	O	O	1298	1306	position	position	I-NP	NN	O	27	PMOD	O
O	O	O	1306	1307	.	.	O	.	O	20	P	O
